Karen Wilson Increases Stake in SER with Recent Purchase

Karen Wilson buys 5,000 shares of SER, adding to her growing stake.

Key Points

  • Karen Wilson bought 5,000 shares of SER at $1.77 each on June 12, 2026, for a total of $8,850.
  • SER shares recently traded at $1.93, with institutional investors like Geode Capital and BlackRock increasing their holdings.
  • Analysts from HC Wainwright & Co. and Jones Trading have set buy ratings with price targets of $15.00 and $11.00, respectively.

Karen Wilson recently increased her stake in SER by purchasing 5,000 shares at an average price of $1.77 per share on June 12, 2026. This transaction, valued at $8,850, adds to her growing investment in the company.

Insider Buying and Selling at Serina Therapeutics, Inc.

Karen Wilson has been active in acquiring SER shares, with her latest purchase of 5,000 shares on June 12, 2026, at $1.77 each. This follows her earlier buys, including 5,100 shares at $1.75 on June 11, and 10,000 shares at $1.93 each on May 22. Other insiders like Steven Ledger, the CEO, also bought 10,100 shares at $1.93 on May 26, while CFO Gregory Curhan and CSO Randall Moreadith made significant purchases in May as well.

Other Institutional Activity in SER

Several institutional investors have been adjusting their positions in SER. SIO Capital Management, LLC added 1,000,000 shares, bringing its total holdings to 1,000,000 shares worth approximately $1,940,000. Vanguard Capital Management LLC also increased its position by 159,136 shares, now holding 159,136 shares valued at about $308,724. Geode Capital Management, LLC more than doubled its stake with an addition of 34,564 shares, ending with 64,973 shares worth $126,049. BlackRock, Inc. significantly boosted its holdings by 41,015 shares, now holding 58,264 shares valued at $113,033.

Analysts Set New Price Targets

Analysts have shown optimism towards SER. On August 28, 2025, HC Wainwright & Co. reiterated their buy rating with a price target of $15.00. Earlier, on July 14, 2025, they initiated coverage with the same buy rating and target. Jones Trading also initiated coverage with a buy rating and an $11.00 price target on March 11, 2025.

Bottom Line

Karen Wilson's recent purchase reflects her continued confidence in SER. Institutional interest and analyst ratings suggest a positive outlook, though these insights are based on past transactions and may not reflect current positions. Investors often track such insider and institutional activities to gauge sentiment and potential future performance.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.